To diet or not to diet – that is still the question

par Rieger, Johannes, Steinbach, Joachim P.
Publié dans Neuro Oncol (2016)

Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostas...

par Wanka, Christina, Steinbach, Joachim P., Rieger, Johannes
Publié 2012

Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma

par Bähr, Oliver, Hattingen, Elke, Rieger, Johannes, Steinbach, Joachim P.
Publié 2011

EGFR and mTOR as therapeutic targets in glioblastoma

par Ronellenfitsch, Michael W., Luger, Anna-Luisa, Steinbach, Joachim P.
Publié dans Oncotarget (2019)

Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy

par Hattingen, Elke, Bähr, Oliver, Rieger, Johannes, Blasel, Stella, Steinbach, Joachim, Pilatus, Ulrich
Publié 2013

Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide

par Maurer, Gabriele D., Heller, Sonja, Wanka, Christina, Rieger, Johannes, Steinbach, Joachim P.
Publié dans Int J Mol Sci (2019)

Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors

par Burger, Michael C., Zeiner, Pia S., Jahnke, Kolja, Wagner, Marlies, Mittelbronn, Michel, Steinbach, Joachim P.
Publié dans PLoS One (2016)

CD95‐mediated Apoptosis of Human Glioma Cells: Modulation by Epidermal Growth Factor Receptor Activity

par Steinbach, Joachim P., Supra, Petra, Huang, H.‐J. Su, Cavenee, Webster K., Weller, Michael
Publié dans Brain Pathol (2006)

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival

par Hattingen, Elke, Jurcoane, Alina, Daneshvar, Keivan, Pilatus, Ulrich, Mittelbronn, Michel, Steinbach, Joachim P., Bähr, Oliver
Publié 2013

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern

par Burger, Michael C., Mildenberger, Iris C., Wagner, Marlies, Mittelbronn, Michel, Steinbach, Joachim P., Bähr, Oliver
Publié dans Int J Mol Sci (2017)

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition

par Urban, Hans, Willems, Laurent M., Ronellenfitsch, Michael W., Rosenow, Felix, Steinbach, Joachim P., Strzelczyk, Adam
Publié dans Oncoimmunology (2020)

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study

par Steidl, Eike, Pilatus, Ulrich, Hattingen, Elke, Steinbach, Joachim P., Zanella, Friedhelm, Ronellenfitsch, Michael W., Bähr, Oliver
Publié dans PLoS One (2016)

ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors

par Bähr, Oliver, Gross, Stefanie, Harter, Patrick N., Kirches, Elmar, Mawrin, Christian, Steinbach, Joachim P., Mittelbronn, Michel
Publié dans Oncol Lett (2017)

Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet

par Voss, Martin, Lorenz, Nadja I., Luger, Anna-Luisa, Steinbach, Joachim P., Rieger, Johannes, Ronellenfitsch, Michael W.
Publié dans Int J Mol Sci (2018)

Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment

par Heinzen, Dennis, Divé, Iris, Lorenz, Nadja I., Luger, Anna-Luisa, Steinbach, Joachim P., Ronellenfitsch, Michael W.
Publié dans Int J Mol Sci (2019)

Single-shot bevacizumab for cerebral radiation injury

par Voss, Martin, Wenger, Katharina J., Fokas, Emmanouil, Forster, Marie-Thérèse, Steinbach, Joachim P., Ronellenfitsch, Michael W.
Publié dans BMC Neurol (2021)

Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a (31)P/(1)H MRSI and quantitative magnetic resonance imaging study

par Hattingen, Elke, Jurcoane, Alina, Bähr, Oliver, Rieger, Johannes, Magerkurth, Jörg, Anti, Sandra, Steinbach, Joachim P., Pilatus, Ulrich
Publié 2011

Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases

par Burger, Michael C., Wagner, Marlies, Franz, Kea, Harter, Patrick N., Bähr, Oliver, Steinbach, Joachim P., Senft, Christian
Publié dans J Clin Med (2018)

INNV-22. TO TREAT OR NOT TO TREAT – TREATMENT OUTCOMES OF VERY ELDERLY GLIOBLASTOMA PATIENTS

par Baumgarten, Peter, Prange, Georg, Harter, Patrick, Forster, Marie-Therese, Wagner, Marlies, Steinbach, Joachim, Seifert, Volker, Senft, Christian
Publié dans Neuro Oncol (2019)

ErbB2/Her2-specific NK cells for adoptive immunotherapy of glioblastoma

par Zhang, Congcong, Burger, Michael, Jennewein, Lukas, Genßler, Sabrina, Grez, Manuel, Tonn, Torsten, Mittelbronn, Michel, Steinbach, Joachim, Wels, Winfried
Publié dans J Immunother Cancer (2014)